Compared with other antidiabetic drugs, semaglutide is associated with a lower risk for Alzheimer disease-related dementia in patients with type 2 diabetes.

The average survival time for a frontotemporal dementia patient is about 8-10 years after symptoms start, though medics say this is highly variable between individuals. It is incurable and ...

Key protein changes could trigger frontotemporal dementia in middle age, a recent study has found. Image credit: Westend61/Getty Images. This article originally appeared on Medical News Today ...

NKGen Biotech Announces Administration of First Dose of Troculeucel to Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program Published. Feb 21, 2025 8:00am EST.

The global frontotemporal dementia market is experiencing robust growth due to the increasing prevalence of neurodegenerative disorders, advancements in diagnostic and therapeutic technologies, and ...

In a significant achievement for identifying neurodegenerative diseases early, a team of US researchers has developed a new ...

— Frontotemporal dementia: This is a rare form that develops in people younger than 60, ... A Patient’s Guide to Dementia originally appeared on usnews.com. Update 02/26/25: ...

SANTA ANA, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and ...